Belfast, United Kingdom

Raghu Raj Singh Thakur

USPTO Granted Patents = 1 


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Raghu Raj Singh Thakur

Introduction

Raghu Raj Singh Thakur is a notable inventor based in Belfast, GB. He has made significant contributions to the field of ocular compositions, showcasing his expertise and innovative spirit. His work is particularly focused on developing advanced ocular implants that can enhance therapeutic delivery.

Latest Patents

Thakur holds a patent for his invention titled "Ocular compositions." This invention provides methods for creating microparticle and nanoparticle ocular implants from a composition that includes 99 to 60% (w/w) of a photopolymerizable composition. This composition is selected from fragments or monomers such as polyalkylene glycol diacrylate and polyalkylene glycol dimethacrylate, with a molecular weight ranging from 100 to 20,000 Dalton. Additionally, it incorporates a biodegradable polymer, a photoinitiator, and a therapeutic agent. Thakur's innovative approach has the potential to revolutionize ocular treatments.

Career Highlights

Raghu Raj Singh Thakur is affiliated with The Queen's University of Belfast, where he contributes to research and development in ocular technologies. His academic background and research endeavors have positioned him as a key figure in his field. Thakur's dedication to innovation is evident in his patent and ongoing research projects.

Collaborations

Thakur has collaborated with esteemed colleagues, including David S Jones and Rahul Sonawane. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research.

Conclusion

Raghu Raj Singh Thakur's contributions to ocular compositions exemplify the spirit of innovation in the field of medical technology. His patent and collaborative efforts highlight the importance of research in developing advanced therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…